The Vaccine tracker provides an overview of the progress in the rollout of COVID-19 vaccines in the EU/EEA. It presents detailed information on the number of vaccine doses distributed by manufacturers to each country for the different vaccines authorised for use in the EU and the number of doses and full vaccinations administered to adult individuals (18+), the total population and by age groups, including below 18 years of age, as well as among specific target groups, healthcare workers (HCW) and in residents in long-term care facilities (LTCF). The total population includes children and adolescents for whom the vaccine is not available or who may not be included in national target groups yet.

A weekly COVID-19 Country Overview report is published every week on Thursdays with updated information on the COVID-19 vaccine rollout in the EU/EEA.

As a general disclaimer, data should be interpreted with caution, including comparisons across countries. For their correct interpretation, all possible factors affecting vaccine deployment in each country should be considered, as well as data completeness and quality. Data quality is consistently monitored and discussed with countries. Data may be retrospectively corrected.

Vaccine doses administered to individuals below 18 years mostly include doses administered to individuals in the age range of 12 to 17 years, since Comirnaty and Spikevax are currently authorised for use in people aged 12 years and older, and to a lesser extent doses administered “off label” to children below 12 years with vulnerabilities.